You have no items in your shopping cart.
Cart summary
αGalCer-RBD
Catalog Number: orb1983034
Product Properties
| Catalog Number | orb1983034 |
|---|---|
| Category | Small Molecules |
| Description | αGalCer-RBD, a conjugate of the potent invariant natural killer T cell (iNKT) agonist α-Galactosylceramide (αGalCer) and the receptor-binding domain (RBD), serves as a self-adjuvanting lipoprotein that exhibits strong potential as a COVID-19 vaccine candidate. This compound effectively induces immunity against SARS-CoV-2 and its variants of concern by promoting the development of RBD-specific, cytokine-producing T cells. |
| Target | Others |
| MW | 1119.6 |
| Formula | C60H118N4O14 |
| Storage | -20°C |
| Note | For research use only |
Images
Reviews
αGalCer-RBD (orb1983034)
- 0.0
Based on 0 reviews
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Step 1: Enter information below
(Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation
(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
% DMSO +
%+
% Tween 80 +
%
